Story
FTSE 100 Gains as Easing U.S.-Iran Tensions Send Oil Prices Tumbling
Summary
London's blue-chip index rose Monday, joining a broader European rally, as a pause in military hostilities between the U.S. and Iran eased investor fears and triggered a sharp decline in crude oil prices.
London's FTSE 100 index advanced in early trading Monday, buoyed by signs of de-escalation in the Middle East after a pause in military strikes between the United States and Iran held for a third consecutive night.
Market Reaction
As of 07:35 GMT, the FTSE 100 was up 0.42%, tracking gains across the continent. Germany’s DAX index outperformed with a 1.3% rise, while France’s CAC 40 added 0.72%, according to Investing.com data.
The easing of geopolitical tensions had a significant impact on commodity markets. The reduced risk premium sent crude oil prices sharply lower, with Brent crude falling 5.2% to $86.94 a barrel and West Texas Intermediate (WTI) dropping 5.6% to $84.32. Conversely, gold continued to attract safe-haven bids, with spot gold rising 1.2% to $4,102.82 an ounce.
In currency markets, the British pound firmed slightly against the U.S. dollar, with the GBP/USD pair trading up 0.16% at 1.3345.
Geopolitical Backdrop
AdThe market's positive sentiment follows reports that the U.S. has paused its bombing campaign. An Axios report on Sunday stated that top U.S. military commander Adm. Bradley Cooper advised the president that the campaign had "reached the limits of its effectiveness," influencing the decision to halt strikes.
Iran has also paused its attacks, which it termed "retaliatory." Army spokesperson Mohammad Akraminia confirmed the halt, linking it directly to the pause in U.S. military action. Despite the apparent truce, U.S. officials cautioned that the situation remains fluid, with UN ambassador Mike Waltz telling NBC that President Trump is "keeping all options on the table."
UK Corporate Movers
Several large-cap UK companies provided positive updates, supporting the index's advance:
- AstraZeneca (AZN): The pharmaceutical giant beat second-quarter profit forecasts and reaffirmed its full-year outlook, citing strong demand for its cancer and cardiovascular drugs.
- Vodafone (VOD): The telecom company raised its full-year guidance, attributing the upgrade to a strong start to the year and the impact of its Safaricom transaction.
- Cranswick (CWK): The food producer reported higher first-quarter revenue on robust volume growth, maintaining its outlook for the full year.
Read next
More on Stocks
European Telecoms Face AI-Driven Price Pressure, Bank of America Warns
Bank of America analysts report that while AI agents could increase customer churn for European telecom operators by simplifying price comparisons, the technology also offers powerful tools for sales and personalized customer retention.
ShinyHunters Hackers Renew Attacks on Oracle PeopleSoft Flaw, Google's Mandiant Reports
Google's cybersecurity unit, Mandiant, reports that the hacking group ShinyHunters has resumed and adapted its exploitation of a known vulnerability in Oracle's PeopleSoft enterprise software, targeting organizations that failed to apply a full security patch.
Manulife Stock Climbs, Supported by Cross-Border Investor Optimism
Shares of Manulife Financial gained on Tuesday, buoyed by a strong performance in U.S. markets rather than any specific company news. The stock's move is also supported by a bullish technical posture and positive analyst ratings.
Escondida Union Rejects BHP's Bid to Pause Talks After Fatal Accident
A union at the world's largest copper mine, Escondida, has rejected a request from operator BHP to postpone contract negotiations following a fatal accident earlier this week. The union accused the company of using the tragedy to delay the collective bargaining process.